Orlistat and sibutramine are currently approed for long-term use, while rimonabant is under reiew by the US Food and Drug Administration.

• 当前奥利斯特和西布曲明被批准可长期服用，而与此同时利莫那班却仍然在接受美国食品药品监督管理局的观察。